Tagged with J

Japan Yuzo Toda, chairman of the Forum for Innovative Regenerative Medicine (FIRM) in Japan, discusses how the organization acts as a translational bridge between academia and industry, how the paradigm of regenerative medicine differs from that of traditional pharmaceuticals, and why Japan has taken the lead in this exciting new field.…

Japan Dr. Tatsuya Kondo is chief executive of Japan’s regulatory authority, the Pharmaceuticals and Medical Devices Agency (PMDA). Since taking the role in 2008, Dr. Kondo, a qualified neurosurgeon with wide-ranging experience in R&D activities, has been responsible for all the operations of PMDA, including relief for adverse health effects of…

Canada Louis Pilon, president and CEO, highlights JAMP Pharma’s unique positioning as a Canadian generics company with one of the largest salesforce covering the whole Canadian market as well as the fourth-largest product portfolio, their focus on niche and complex products, their agility in seizing new opportunities, and his mission to…

India As a young pathbreaking transformer in the Indian pharmaceutical landscape, Yogesh Agrawal, managing director of Ajanta Pharma Ltd., shares his desire to accelerate the company’s expansion in the US. Out of the total revenues of USD 308 million for FY17, the USA accounted for 28 million. He talks about the…

Japan Makoto Suematsu, president of the Japan Agency for Medical Research and Development (AMED), discusses AMED’s successful unification of Japan’s previously disparate systems for medical research funding; the strategic significance of the country’s strong footprint in regenerative medicine and rare diseases; and the organization’s internationalization strategy, propelled by the push to…

Colombia With Latin America’s best healthcare system in terms of both coverage and quality, Colombia is fast becoming a destination of choice for multinationals, not only to set up shop in the sense of establishing a direct local affiliate, but also for opening regional headquarters and implanting managerial functions. “We are…

Austria Bernd Grabner, board member of Jacoby GM pharma, a leading Austrian wholesaler, provides an in-depth look into the historical merger of family owned Jacoby, GM pharma and Kӧgl Pharma as well as the moves being made to bolster a vertically integrated business model. Furthermore, he gives an overview of the…

Colombia Dr. Sanjay Machado, the Vice President of Global Operations and Integrations for JSS Medical Research Inc., (JSS) a Canadian based international Contract Research Organisation, elaborates on the rapid expansion of the company through strategic acquisitions, the full range of clinical research-related services of JSS and the company’s vision to expand…

Indonesia Indonesia in figures. Indonesia’s population is projected to grow to 305.6 million by 2035. Indonesia’s universal healthcare coverage program (JKN) has grown exponentially in recent years to cover around 172 million people in 2016. Indonesia spends less on healthcare than many of its regional peers, with only Laos and Myanmar…

Indonesia Maura Linda Sitanggang, director general at the Indonesian Ministry of Health, discusses the plans being rolled out to ensure that all Indonesians have access to medicines and how the Indonesian pharmaceutical industry has developed its self-reliance and innovativeness. How does the Ministry of Health organize its priorities and how far…

Japan Kenichi Tamiya, director for Biomedical Policy at the Kobe City Government and managing director of the Kobe Foundation for Biomedical Research and Innovation (FBRI), discusses the central Japanese city of Kobe’s significant potential as a cutting-edge R&D hub for both the national and global life science industries. “Alongside promoting translational…

Colombia Yolanda Alagón, general manager of Janssen Colombia, discusses the company’s footprint in Colombia and Latin America and her strategy for the affiliate moving forward. You have been appointed General Manager three years ago, becoming one of the first women to lead a pharma company in Latin America. You mentioned your…